Longaeva Partners »

Ultragenyx Pharmaceutical shares owned by Longaeva Partners

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.8M 228k 20.95

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Sands Capital Management
Rtw Investments
FMR
Wellington Management Company
Citadel Advisors
Assenagon Asset Management
Two Sigma Investments
Frontier Capital Management

View all funds holding Ultragenyx Pharmaceutical